HomeCompareAGRX vs PEP

AGRX vs PEP: Dividend Comparison 2026

AGRX yields 132.45% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AGRX wins by $13.39M in total portfolio value
10 years
AGRX
AGRX
● Live price
132.45%
Share price
$1.51
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$13.53M
Annual income
$5,443,687.21
Full AGRX calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — AGRX vs PEP

📍 AGRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAGRXPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AGRX + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AGRX pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AGRX
Annual income on $10K today (after 15% tax)
$11,258.28/yr
After 10yr DRIP, annual income (after tax)
$4,627,134.13/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, AGRX beats the other by $4,574,539.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AGRX + PEP for your $10,000?

AGRX: 50%PEP: 50%
100% PEP50/50100% AGRX
Portfolio after 10yr
$6.84M
Annual income
$2,752,781.45/yr
Blended yield
40.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

AGRX
Analyst Ratings
9
Buy
1
Hold
Consensus: Buy
Price Target
$1.00
-33.8% upside vs current
Range: $1.00 — $1.00
Altman Z
-41.2
Piotroski
3/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AGRX buys
0
PEP buys
0
No recent congressional trades found for AGRX or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAGRXPEP
Forward yield132.45%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$13.53M$141.9K
Annual income after 10y$5,443,687.21$61,875.67
Total dividends collected$12.40M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$1.00$172.43

Year-by-year: AGRX vs PEP ($10,000, DRIP)

YearAGRX PortfolioAGRX Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$23,945$13,245.03$10,849$509.42+$13.1KAGRX
2$55,262$29,640.44$11,969$750.47+$43.3KAGRX
3$123,061$63,930.66$13,500$1,124.14+$109.6KAGRX
4$264,727$133,051.80$15,680$1,721.66+$249.0KAGRX
5$550,752$267,494.95$18,929$2,715.34+$531.8KAGRX
6$1,109,410$520,104.50$24,023$4,450.80+$1.09MAGRX
7$2,166,203$979,134.42$32,510$7,669.92+$2.13MAGRX
8$4,104,595$1,786,757.87$47,709$14,093.60+$4.06MAGRX
9$7,556,038$3,164,121.24$77,415$28,083.48+$7.48MAGRX
10$13,528,648$5,443,687.21$141,922$61,875.67+$13.39MAGRX

AGRX vs PEP: Complete Analysis 2026

AGRXStock

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Full AGRX Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this AGRX vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AGRX vs SCHDAGRX vs JEPIAGRX vs OAGRX vs KOAGRX vs MAINAGRX vs MOAGRX vs PMAGRX vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.